Craig McCulloch at Radio NZ writes:
Monday’s media conference contained a self-evident yet sobering admission: many of those caught in the Delta outbreak were not vaccinated as they were not yet eligible.
The Ministry of Health later confirmed just three of the 107 people who had so far tested positive for Covid-19 were double jabbed; 14 had received one dose.
Yep just 3% of those infected had been fully vaccinated.
Since last week’s Delta incursion, Prime Minister Jacinda Ardern has been unapologetic and dismissive of any criticism of the government’s vaccination campaign.
Ardern has batted away questions by claiming a higher immunisation rate would not have saved New Zealand from lockdown. That may well be the case, but it will come as cold comfort to those individuals cooped up in Jet Park with Covid-19.
As the prime minister herself acknowledged, a “large number” of them were ineligible to be vaccinated, denied the defence which could have protected them from the virus or at least its worst effects.
We are probably the only OECD country that hasn’t made the Covid-19 vaccine available to all adults yet.
New Zealand’s vaccination programme has been staggeringly slow by international standards, among the last in the developed world.
Not among the last. It is the last.
The sluggish pace is in part due to deliberate decisions by the government.
Given the country’s then-Covid-free status, ministers chose not to follow other countries in rushing the vaccine approval processes, instead allowing regulator Medsafe to carry out a months-long rigorous assessment.
Mistake 1. The thought that Medsafe would come to a different conclusion to the FDA and European regulators is farcical.
Most countries are using a wide portfolio of vaccines but in March New Zealand decided to go all in on Pfizer, choosing to inoculate everybody with the same vaccine based on its strong performance and fewer side-effects.
As a result, the government declined deliveries from other suppliers earlier this year. That too has meant a slower rollout.
Mistake 2. We should have taken up orders from all of them. Sure Pfizer is arguably marginally better but would you rather have an 85% effective vaccine in say April or a 87% effective vaccine in October?
In April, Ardern told Parliament New Zealand’s delivery schedule was slower than other countries’ as its people were “not dying while they wait”.
The suggestion is that Pfizer deemed countries like New Zealand and Australia lower priority due to their earlier success in defeating Covid-19. That might also explain why Australia has grappled with similar supply problems.
That is one possibility. Another is that the government’s negotiators came late to the party, did a poor job and got a raw deal.
After all, the government did not sign supply agreements with Pfizer until October last year and then again in March. For comparison, the US and UK reached deals in May last year.
Mistake 3. Too slow.
For months, ministers have rationalised many of the decisions surrounding the vaccine rollout on the basis there was no Covid-19 in the community and so no need to act with undue haste.
That is no longer the case. Delta is here, and there are at least 107 New Zealanders who deserve more than a glib brush-off.
More than 107 now.